Thomas Seoh

Thomas Seoh is CEO of Kinexum, a regulatory and clinical development strategic advisory firm.  Previously, he has held senior leadership positions in public and private pharmaceutical, biotech, and medical device companies for three decades, including CEO of venture-backed Faust Pharmaceuticals in Strasbourg, France (now Domain Therapeutics), and SVP Corporate and Commercial Development of NASDAQ-listed Guilford Pharmaceuticals in Baltimore (now Eisai).  As EVP of the not-for-profit Kitalys Institute,  dedicated to accelerating the translation of advancing science and technology into public health to preempt chronic diseases and extend healthy longevity for all, he is an organizer of the acclaimed Targeting Metabesity (now Targeting Healthy Longevity) conferences and multiple webinars on topics from biological clocks to the molecular and evolutionary bases of exercise as geroprotection and the Dog Aging Project. Thomas holds an AB in Philosophy and History and a JD from Harvard University.